Osteotech adopts Stockholder Rights Plan to discourage unfair takeover tactics

Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, announced today that its Board of Directors adopted a Stockholder Rights Plan.  The rights plan is designed to discourage coercive or unfair takeover tactics and to provide fair and equal treatment for all stockholders of the Company in the event that an unsolicited offer is made to acquire the Company.

To implement the rights plan, the Board authorized the distribution of one right for each outstanding share of common stock of the Company to holders of record as of the close of business on February 2, 2010.  The rights will expire on January 22, 2020.

The rights will initially trade only with the shares of common stock to which they are attached, and generally become exercisable only if a person or group becomes an "Acquiring Person" (as defined in the plan) by accumulating "beneficial ownership" (as defined in the plan) of 15% or more of the Company's outstanding common stock.  At such time, each right will entitle the stockholder (other than an Acquiring Person) to purchase shares of the Company's preferred stock or, in some circumstances, shares of the acquiring person's common stock, having a value equal to twice the exercise price of the right (initially, $23.00 per right).  

The rights plan provides that a person or group currently owning 15% or more of the Company's outstanding common stock will not be deemed to be an "Acquiring Person" if the person or group does not subsequently accumulate an additional 1% of the Company's outstanding common stock through open market purchases, expansion of a group or other means.

The rights plan requires a committee of independent directors to assess every five years whether the rights plan remains in the best interests of the Company's stockholders.  

Additional details regarding the rights plan, including a copy of the plan, will be outlined in the Company's filings with the Securities and Exchange Commission.  These filings will be available on the SEC's website at www.sec.gov.  In addition, the Company will make available to its stockholders, upon request and at no charge to them, a "Summary of the Rights" (a copy of which will also be filed with the SEC) that describes the material terms of the rights plan.

Source:

Osteotech, Inc.

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.